Whitehawk Therapeutics

(NASDAQ) AADI

Current PriceN/A

Market CapN/A

Since IPO (2021)-85%

5 Year-76%

1 Year+135%

1 Month+16%

Whitehawk Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$115.81M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

AADI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Whitehawk Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Lennon, PhD

Website

www.whitehawktx.com

Headquarters

Pacific Palisades, CA 90272, US

AADI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-80%

Return on Capital

-1%

Return on Assets

-91%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$114.40M

EBITDA

$114.40M

Operating Cash Flow

$97.43M

Capital Expenditure

$552.00K

Free Cash Flow

$97.98M

Cash & ST Invst.

$145.70M

Total Debt

$0.00

Whitehawk Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$22.19M

-130.4%

EBITDA

$23.52M

-132.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$123.04M

-46.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-91.02%

N/A

Return on Invested Capital

-1.06%

N/A

Free Cash Flow

$22.21M

-78.9%

Operating Cash Flow

$22.21M

-87.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMDXInsight Molecular Diagnostics Inc.

IMDXInsight Molecular Diagnostics Inc.$5.07+1.81%

BLIBerkeley Lights, Inc.

BLIBerkeley Lights, Inc.$1.20-5.88%

JNCEJounce Therapeutics, Inc.

JNCEJounce Therapeutics, Inc.$1.88+0.00%

MIROMiromatrix Medical Inc.

MIROMiromatrix Medical Inc.$3.39+0.59%

HLVXHilleVax, Inc.

HLVXHilleVax, Inc.$2.09-0.48%

IGMSIGM Biosciences, Inc.

IGMSIGM Biosciences, Inc.$1.27+0.00%

KNTEKinnate Biopharma Inc.

KNTEKinnate Biopharma Inc.$2.65-0.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$17.07+0.07%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.94+0.10%

NOKNokia

NOKNokia$14.19+0.08%

VNETVnet Group

VNETVnet Group$11.34+0.26%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.50-0.02%

POETPoet Technologies

POETPoet Technologies$13.90+0.01%

QUBTQuantum Computing

QUBTQuantum Computing$11.15-0.05%

Questions About AADI

What is the current price of Whitehawk Therapeutics?

Whitehawk Therapeutics is trading at N/A per share.

What is the 52-week range for Whitehawk Therapeutics?

Over the past 52 weeks, Whitehawk Therapeutics has traded between N/A and N/A.

How much debt does Whitehawk Therapeutics have?

As of the most recent reporting period, Whitehawk Therapeutics reported total debt of N/A.

How much cash does Whitehawk Therapeutics have on hand?

Whitehawk Therapeutics reported $34.79M in cash and cash equivalents in its most recent financial results.

What is Whitehawk Therapeutics’s dividend yield?

Whitehawk Therapeutics does not currently have a dividend yield.

Whitehawk Therapeutics

Whitehawk Therapeutics Financials at a Glance

AADI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Whitehawk Therapeutics

AADI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Whitehawk Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AADI

What is the current price of Whitehawk Therapeutics?

What is the 52-week range for Whitehawk Therapeutics?

How much debt does Whitehawk Therapeutics have?

How much cash does Whitehawk Therapeutics have on hand?

What is Whitehawk Therapeutics’s dividend yield?

Premium Investing Services